764 related articles for article (PubMed ID: 32143060)
1. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
2. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy.
Yang Y; Zuo S; Li L; Kuang X; Li J; Sun B; Wang S; He Z; Sun J
Asian J Pharm Sci; 2021 Nov; 16(6):784-793. PubMed ID: 35027953
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
[TBL] [Abstract][Full Text] [Related]
4. Activatable unsaturated liposomes increase lipid peroxide of cell membrane and inhibit tumor growth.
Fu JJ; Liu CC; Feng GN; Li SP; Yu YY; Du LR; Zhang JY; Zhang Y; Lei XP; Dai X; Yu XY
Biomater Adv; 2023 Apr; 147():213323. PubMed ID: 36764198
[TBL] [Abstract][Full Text] [Related]
5. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
6. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy.
Xing L; Liu XY; Zhou TJ; Wan X; Wang Y; Jiang HL
J Control Release; 2021 Nov; 339():14-26. PubMed ID: 34547257
[TBL] [Abstract][Full Text] [Related]
7. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
8. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer.
Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W
Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546
[No Abstract] [Full Text] [Related]
10. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
12. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
13. Ferrocene-liposome-PEG: a robust ˙OH/lipid peroxide nano-converter for inducing tumor ferroptosis.
Liu Y; Chen J; He Z; Luo H; Liu X; Sun Y; Ge D; Liu X; Shi W
Biomater Sci; 2023 Jan; 11(2):542-553. PubMed ID: 36472166
[TBL] [Abstract][Full Text] [Related]
14. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
15. Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators.
Kajarabille N; Latunde-Dada GO
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597407
[TBL] [Abstract][Full Text] [Related]
16. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
[TBL] [Abstract][Full Text] [Related]
17. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
18. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
19. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
